MacLean Michael F (CIK 1383731) reported 8 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-02-27). Recent activity: Sell RNAM (133,977 shares), Sell RNA (1,807 shares), Sell RNA (2,735 shares), Sell RNA (1,974 shares), Sell RNA (30,914 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-27 | Avidity Biosciences, Inc. (RNAM) | Chief Financial Officer | Sell | 133,977 | $0 |
| 2026-01-23 | Avidity Biosciences, Inc. (RNA) | Chief Financial Officer | Sell | 1,807 | $130,917 |
| 2026-01-23 | Avidity Biosciences, Inc. (RNA) | Chief Financial Officer | Sell | 2,735 | $198,151 |
| 2026-01-09 | Avidity Biosciences, Inc. (RNA) | Chief Financial Officer | Sell | 1,974 | $142,582 |
| 2025-08-15 | Avidity Biosciences, Inc. (RNA) | Chief Financial Officer | Sell | 30,914 | $1.3M |
| 2025-03-21 | Avidity Biosciences, Inc. (RNA) | Chief Financial Officer | Sell | 7,935 | $246,461 |
| 2025-01-23 | Avidity Biosciences, Inc. (RNA) | Chief Financial Officer | Sell | 1,622 | $46,373 |
| 2025-01-23 | Avidity Biosciences, Inc. (RNA) | Chief Financial Officer | Sell | 1,665 | $47,602 |
Source: SEC Form 4 filings · as of 2026-02-27